2026 Speakers

Olivia Newton-John Cancer Research Institute

READ BIO

Head, Tumour Targeting Laboratory

Co-Director, Centre for Research Excellence in Brain Cancer

Director, Department Of Molecular Imaging And Therapy, Austin Health

Prof. Andrew Scott leads the Tumour Targeting Laboratory at the Olivia Newton-John Cancer Research Institute and co-Director, Centre for Research Excellence in Brain Cancer; is Director, Department of Molecular Imaging and Therapy, Austin Health; and is Professor, La Trobe University and The University of Melbourne.

His clinical and research interests are focused on developing innovative strategies for targeted therapy of cancer (particularly with monoclonal antibodies), molecular imaging in oncology, and global advocacy in Oncology and Nuclear Medicine. His laboratory has been involved in the preclinical development and first-in-man trials of numerous recombinant antibodies in cancer patients, and seven antibodies developed in his laboratory have been licenced to Biotech and Pharma companies, and have entered Phase I/II/III trials. He has published over 480 peer reviewed papers and 27 book chapters, is an inventor on 25 patents, and is a founder of a biotech company.

Prof Scott is actively involved in the training and mentoring of young scientists and clinicians, and is currently supervising several doctoral students, postdoctoral fellows and nuclear medicine trainees.

Another focus of his work is strategic planning for training, health care policy, and molecular imaging and nuclear medicine therapy advocacy within the US, European, South American, Asia-Oceania, and African regions, as well as with the IAEA and WHO and he also participates in policy and governance activities with the Australian Government. Prof Scott is former president of the World Federation of Nuclear Medicine and Biology, the peak global nuclear medicine organisation. In 2017 he was awarded Member (AM) in the General Division of the Order of Australia, and elected a Fellow of the Australian Academy of Health and Medical Sciences. In 2022 Prof Scott received the Saul Hertz award from SNNMI and Ajit Padhy award from WARMTH. In 2023 he received the Telix Award from ANZSNM, and in 2024 Prof Scott was elected Fellow, Society of Nuclear Medicine and Molecular Imaging, USA

Amsterdam University Medical Center

READ BIO

My lab's mission is to redefine Standard Radiotherapy

As radiation oncologists, we want to treat cancer patients with high precision radiotherapy. The UMC Utrecht has the right team and right machinery for this (3x MRI-linac, 10x CT-linac). My lab's goal is to design the best cancer treatment for each patient. Some patients want to live as long as possible regardless of treatment side effects, others want quality of life. To find balance is key.

The UMC Utrecht department of Radiation Oncology is a terrific place to do clinical research, as it is even the birthplace of the MRI-linac. Next, the Radiation Oncology department harbours 2 1.5T MRI systems, a 3.0T MRI, a 7.0T MRI and a MRI/PET scanner.

Joost Verhoeff subspecialized in treatment of brain tumors, lung cancer and cardiac SBRT. About half of his time he spends on research as associate professor.